Dermatomyositis and Hydrocephalus

Summary:

Hydrocephalus is found among people with Dermatomyositis, especially for people who are male, 40-49 old.

The study analyzes which people have Hydrocephalus with Dermatomyositis. It is created by eHealthMe based on reports of 12 people who have Dermatomyositis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Dermatomyositis?

Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer) is found to be associated with 262 drugs and 416 conditions by eHealthMe. Check the latest studies of Dermatomyositis.

What is Hydrocephalus?

Hydrocephalus (water on the brain) is found to be associated with 751 drugs and 1,370 conditions by eHealthMe. Check the latest studies of Hydrocephalus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

12 people who have Dermatomyositis and Hydrocephalus are studied.

Would you have Hydrocephalus when you have Dermatomyositis?

Gender of people who have Dermatomyositis and experienced Hydrocephalus *:

female: 33.33 %
male: 66.67 %

Age of people who have Dermatomyositis and experienced Hydrocephalus *:

Common co-existing conditions for these people *:

Sinusitis (inflammation of sinus): 3 people, 25.00%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 1 person, 8.33%
Menstruation Irregular: 1 person, 8.33%
Listeriosis (a food borne illness caused by listeria monocytogenes, bacteria found in soil and water): 1 person, 8.33%
Encephalitis Brain Stem (rare inflammatory disorder of the central nervous system): 1 person, 8.33%

Common drugs taken by these people *:

Yasmin: 2 people, 16.67%
Vioxx: 2 people, 16.67%
Risedronate Sodium: 2 people, 16.67%
Prednisolone: 2 people, 16.67%
Mycophenolate Mofetil: 2 people, 16.67%
Hydroxychloroquine Sulfate: 2 people, 16.67%
Vancomycin: 1 person, 8.33%
Sandimmune: 1 person, 8.33%
Omeprazole: 1 person, 8.33%

Common symptoms for these people *:

Brain Stem Haemorrhage (bleeding into structures of brain stem): 8 people, 66.67%
Listeriosis (a food borne illness caused by listeria monocytogenes, bacteria found in soil and water): 8 people, 66.67%
Encephalitis Brain Stem (rare inflammatory disorder of the central nervous system): 8 people, 66.67%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 7 people, 58.33%
Facial Paralysis (loss of function of face muscle): 4 people, 33.33%
Hemiparesis (weakness on one side of the body): 4 people, 33.33%
Visual Field Defect: 2 people, 16.67%
Heart Rate Irregular: 2 people, 16.67%
Lung Disorder (lung disease): 2 people, 16.67%
Vision Blurred: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hydrocephalus?

- Check whether Hydrocephalus is associated with a drug or a condition

Related publications that referenced our studies

Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .
Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .

Related studies:

Treatments, associated drugs and conditions:

Dermatomyositis (8,399 reports)
Hydrocephalus (6,876 reports)

All the drugs that are associated with Hydrocephalus:

Hydrocephalus (751 drugs)

All the conditions that are associated with Hydrocephalus:

Hydrocephalus (1,370 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hydrocephalus and Dermatomyositis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.